US Stocks
/
Kalaris Therapeutics, Inc. Share Price
Kalaris Therapeutics, Inc. Share Price

Kalaris Therapeutics, Inc. Share Price

NASDAQ: KLRS | Micro Cap
$3.16
+$0.03 (0.96%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Kalaris Therapeutics, Inc. Stock Performance

Open
$3.08
Prev. Close
$3.13
Circuit Range
N/A
Day Range
$3.04 - $3.19
Year Range
$3.04 - $11.81
Volume
6,002
Average Traded
$3.08

Kalaris Therapeutics, Inc. Share Price Today

As of 19 September 2026, Kalaris Therapeutics, Inc.'s share price is $3.16. The stock opened at $3.08, compared to its previous close of $3.13. During today's trading session, Kalaris Therapeutics, Inc.'s share price traded between $3.04 and $3.19, with an average price of $3.11. Over the past 52 weeks, the stock has recorded a high of $11.81 and a low of $3.04. In terms of performance, Kalaris Therapeutics, Inc.'s share price has declined by 45.52% over the last six months and is down 45.42% on a year-on-year basis.

Kalaris Therapeutics, Inc. Share Price Chart

$3.04$3.19
L
Show Current Price
H

Kalaris Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$48.25M
PE Ratio (TTM)
-1.11
Dividend Yield
N/A
EPS (TTM)
$-2.85
Revenue (TTM)
N/A
Return On Equity (TTM)
-55.11%
Profit Margin
N/A
Debt to Equity
0.12
Quarterly Earnings Growth YoY
-188.27%

Kalaris Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$30.30M-$6.08M-$4.13M-$10.20M-$11.35M-$11.89M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A79.95%32.09%-147.12%-11.32%-4.79%

Kalaris Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
RevenueN/AN/AN/AN/A
Net Profit-$168.71M-$190.42M-$58.77M-$43.44M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-12.87%69.14%26.09%

About Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California.

Kalaris Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$3.91
$3.19
-23.71%
Aug 2026
$3.67
$4.17
+17.94%
Jul 2026
$4.43
$3.54
-15.61%
Jun 2026
$5.18
$4.20
-19.02%
May 2026
$5.50
$5.18
-5.99%
Apr 2026
$5.67
$5.51
-5.00%
Mar 2026
$10.45
$5.80
-43.85%
Feb 2026
$9.25
$10.33
+16.46%
Jan 2026
$8.12
$8.87
+5.34%
Dec 2025
$5.95
$8.42
+35.70%
Nov 2025
$4.81
$6.21
+27.67%
Oct 2025
$6.26
$4.86
-16.06%

KLRS Share Price FAQs

What is Kalaris Therapeutics, Inc. share price today?

chevron-up
Kalaris Therapeutics, Inc. share price today is $3.16 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Kalaris Therapeutics, Inc. stock?

chevron-up
The 52 week high of Kalaris Therapeutics, Inc. stock is $11.81, while the 52 week low is $3.04 as of 19 Sep '26.

What is KLRS's market capitalisation today?

chevron-up
KLRS market capitalisation is $48.25M as of September 19, 2026, at 3:50 pm IST.

What is KLRS's net income for the last quarter?

chevron-up
KLRS's net income for the last quarter is -0.01B USD.

What is the 5 year returns of KLRS?

chevron-up
The 5 year returns of KLRS is -99.45% as on 19 Sep '26.

What is the high & low stock price of KLRS today?

chevron-up
KLRS stock price hit a high of $3.19 and low of $3.04 as of 19 Sep '26.

Can I buy KLRS shares in India?

chevron-up
Yes. You can buy KLRS in India by opening an international trading account.